EXTH-48. ORAL GALLIUM MALTOLATE IMPAIRS TUMOR GROWTH AND EXTENDS DISEASE-SPECIFIC SURVIVAL IN A XENOGRAFT MODEL OF RECURRENT GBM

BACKGROUND: Recurrent glioblastoma (rGBM) is a distinctly different disease condition than de novo GBM, characterized by chemo- and radioresistance. Consequently, treatment options remain limited. Given our recently published promising results using the novel iron mimetic, gallium maltolate (GaM), i...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Neuro Oncol
Päätekijät: Al-Gizawiy, Mona, Robert, Wujek, Alhajala, Hisham, Cobb, Jonathan, Prah, Melissa, Mirza, Shama, Chitambar, Christopher, Schmainda, Kathleen
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2018
Aiheet:
Abstracts
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6217361/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.396
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia